News from emphycorp inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 05, 2021, 08:43 ET EmphyCorp Inc. Non-Steroidal N115 Nasal Spray Completed Phase III Clinical Trial for COVID-19, Long COVID-19 (Long Haulers), and Pulmonary Fibrosis

EmphyCorp Inc. www.EmphyCorp.com, a private corporation, specializes in Rx Non-Steroidal Nasal Spray Technology. Their flagship product, N115, has...

Apr 07, 2020, 13:20 ET EmphyCorp N115 News: Reducing the Rate and Spread of COVID-19 with Nasal Nitric Oxide

Dr. Alain Martin, who invented Advanced Neosporin, Neosporin Cold Sore Treatment, Advanced Therapy Lubriderm, Rx Rezulin (Type II Diabetes), an FDA...

Mar 24, 2020, 11:47 ET EmphyCorp News: As Reported in The Lancet - Clinical Features of Patients Infected with the 2019 novel Coronavirus in Wuhan, China

EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, specializes in Rx Non-Steroidal Nasal Spray Technology with no known side effects for all...

Mar 17, 2020, 15:04 ET EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus

EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, is proud to announce that EmphyCorp Rx N115 Non-Steroidal Nasal Spray with no known side...

Jan 21, 2020, 12:59 ET EmphyCorp N115 Rx Globally Patented Non-Steroidal Nasal Spray with No Known Side Effects for Pregnant Women with Allergic Rhinitis or Asthma

EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, was proud to announce on January 14th, 2020 the use of its globally patented non-steroidal...

Jan 14, 2020, 11:29 ET Rx Globally Patented Non-Steroidal Nasal Spray for All Lung Diseases including Pulmonary Fibrosis, CF, COPD, Unmet Needs with No Known Side Effects that can also be used to Deliver Antivirals, Antimicrobials, Insulin, and other Drugs

EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, was proud to announce on August 12, 2019, the completion of a clinical trial to define...

Aug 15, 2019, 10:08 ET EmphyCorp Inc. FDA Submission for Rx New Non-Steroidal Nasal Spray for Pulmonary Fibrosis w/ No Known Side Effects

EmphyCorp Inc. www.EmphyCorp.com, a Private Corporation, is proud to announce the completion of a clinical trial to define medical endpoints as...